Guardant Health

Guardant Health: Series F Funding Round

Guardant Health has successfully raised $360M in Series F funding, reaching a valuation of $12B.

Company Overview

Liquid biopsy cancer detection

Funding Details

The Series F round was led by SoftBank Vision Fund, with participation from Baillie Gifford, T. Rowe Price, Khosla Ventures, Sequoia Capital.

Company Information

• Headquarters: 505 Penobscot Drive, Redwood City, CA 94063
• Founded: 2012
• Employees: 1400+
• Category: Biotech

Investment

Guardant Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• SoftBank Vision Fund: Verified investor in Series F
• Baillie Gifford: Verified investor in Series F
• T. Rowe Price: Verified investor in Series F
• Khosla Ventures: Verified investor in Series F
• Sequoia Capital: Verified investor in Series F